Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Ulaner

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
The American Journal of Medicine|August 17, 2004
Telomere maintenance in clinical medicineGary A Ulaner
Clinical Nuclear Medicine|May 2, 2024
Negative 18 F-Piflufolastat PET/CT, But Positive 18 F-Fluciclovine PET/CT, in a Patient With Biochemically Recurrent Prostate CancerGary A Ulaner
Seminars in Nuclear Medicine|April 5, 2022
16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast CancerGary A Ulaner
Clinical Nuclear Medicine|February 17, 2023
Breast Cancer and Physiologic Avidity From Breast Feeding on FDG PET/CTGary A Ulaner
AJR. American Journal of Roentgenology|May 8, 2019
PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?Gary A Ulaner
Seminars in Hematology|April 5, 2026
Targeted immunoPET imaging of multiple myelomaGary A Ulaner, Ola Landgren
Clinical Nuclear Medicine|August 15, 2012
False-positive FDG PET/CT due to liver parenchymal injury caused by a surgical retractorAshima Lyall, Gary A Ulaner
Clinical Nuclear Medicine|September 21, 2022
False-Positive for Pulmonary Emboli on Ventilation/Perfusion Scan Due to Improper Patient Positioning During Tracer AdministrationGary A Ulaner, Catalan Grigore
Clinical Nuclear Medicine|December 18, 2012
Hill-Sachs lesion on FDG PET/CTGary A Ulaner, Sanjit Tewari
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 11, 2013
Identifying and distinguishing treatment effects and complications from malignancy at FDG PET/CTGary A Ulaner, Ashima Lyall
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
The American Journal of Medicine|August 17, 2004
Telomere maintenance in clinical medicineGary A Ulaner
Clinical Nuclear Medicine|May 2, 2024
Negative 18 F-Piflufolastat PET/CT, But Positive 18 F-Fluciclovine PET/CT, in a Patient With Biochemically Recurrent Prostate CancerGary A Ulaner
Seminars in Nuclear Medicine|April 5, 2022
16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast CancerGary A Ulaner
Clinical Nuclear Medicine|February 17, 2023
Breast Cancer and Physiologic Avidity From Breast Feeding on FDG PET/CTGary A Ulaner
AJR. American Journal of Roentgenology|May 8, 2019
PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?Gary A Ulaner
Seminars in Hematology|April 5, 2026
Targeted immunoPET imaging of multiple myelomaGary A Ulaner, Ola Landgren
Clinical Nuclear Medicine|August 15, 2012
False-positive FDG PET/CT due to liver parenchymal injury caused by a surgical retractorAshima Lyall, Gary A Ulaner
Clinical Nuclear Medicine|September 21, 2022
False-Positive for Pulmonary Emboli on Ventilation/Perfusion Scan Due to Improper Patient Positioning During Tracer AdministrationGary A Ulaner, Catalan Grigore
Clinical Nuclear Medicine|December 18, 2012
Hill-Sachs lesion on FDG PET/CTGary A Ulaner, Sanjit Tewari
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 11, 2013
Identifying and distinguishing treatment effects and complications from malignancy at FDG PET/CTGary A Ulaner, Ashima Lyall
Pageof 16